Abstract:Background: Achalasia is an oesophageal motility disorder, of unknown cause, which results in increased lower oesophageal sphincter (LOS) tone and symptoms of difficulty swallowing. Treatments are aimed at reducing the LOS tone. Current endoscopic therapeutic options include pneumatic dilation (PD) or botulinum toxin (BTX) injection. Objectives: To undertake a systematic review comparing the efficacy and safety of two endoscopic treatments, PD and intrasphincteric BTX injection, in the treatment of oesophageal achalasia. Search methods: Trials were initially identified by searching MEDLINE (1966 to August 2008), EMBASE (1980 to September 2008), ISI Web of Science (1955 to September 2008), The Cochrane Library Issue 3, 2008. Searches in all databases were conducted in October 2005 and updated in September 2008 and April 2014. The Cochrane highly sensitive search strategy for identifying randomised trials in MEDLINE, sensitivity maximising version in the Ovid format, was combined with specific search terms to identify randomised controlled trials in MEDLINE. The MEDLINE search strategy was adapted for use in the other databases that were searched. Selection criteria: Randomised controlled trials comparing PD to BTX injection in individuals with primary achalasia. Data collection and analysis: Two review authors independently performed study quality assessment and data extraction. Main results: Seven studies involving 178 participants were included. Two studies were excluded from the meta-analysis of remission rates on the basis of clinical heterogeneity of the initial endoscopic protocols. There was no significant difference between PD or BTX treatment in remission within four weeks of the initial intervention; with a risk ratio of remission of 1.11 (95% CI 0.97 to 1.27). There was also no significant difference in the mean oesophageal pressures between the treatment groups; with a weighted mean difference for PD of -0.77 (95% CI -2.44 to 0.91, P = 0.37). Data on remission rates following the initial endoscopic treatment were available for three studies at six months and four studies at 12 months. At six months 46 of 57 PD participants were in remission compared to 29 of 56 in the BTX group, giving a risk ratio of 1.57 (95% CI 1.19 to 2.08, P = 0.0015); whilst at 12 months 55 of 75 PD participants were in remission compared to 27 of 72 BTX participants, with a risk ratio of 1.88 (95% CI 1.35 to 2.61, P = 0.0002). No serious adverse outcomes occurred in participants receiving BTX, whilst PD was complicated by perforation in three cases. Authors' conclusions: The results of this meta-analysis suggest that PD is the more effective endoscopic treatment in the long term (greater than six months) for patients with achalasia.

Effect of esophageal body recoil on clinical outcomes in non‐spastic achalasia

Improvement of Endoscopical Therapy for Achalasia

An overview of the efficacy, safety, and predictors of achalasia treatments

Utility of Intraprocedural Luminal Diameter and Distensibility Measurements During the Esophageal Peroral Endoscopic Myotomy Procedure

Identification Of Achalasia Within Absent Contractility Phenotypes On High-Resolution Manometry: Prevalence, Predictive Factors And Treatment Outcome

A Systematic Review and Meta-Analysis of the Chinese Literature for the Treatment of Achalasia

The Clinical Efficacy, and Long-Term Outcomes Between Pneumatic Dilation and Laparoscopic Heller Myotomy in Achalasia

Clinical impact of esophageal muscle thickness on peroral endoscopic myotomy patients

Recurrent achalasia treated with Heller myotomy: a review of the literature.

Endoscopic pneumatic dilation versus botulinum toxin injection in the management of primary achalasia

Focal distal esophageal dilation (blown-out myotomy) after achalasia treatment: prevalence and associated symptoms

Esophageal tortuosity in achalasia: increased length-to-height ratio predicts inferior symptom relief and esophageal emptying following myotomy

Autonomic and Neuroendocrine Responses to Rectosigmoid Stimulation

Treatment of Achalasia with Endoscopic Balloon Dilatation.

Butterfly Wings Effect on High Resolution Manometry in A Patient with Esophageal Achalasia

The relationship between cardiac muscularis propria and clinical outcomes of peroral endoscopic myotomy in achalasia

Current status of achalasia management: a review on diagnosis and treatment

Influence of Achalasia on the Spirometry Flow–Volume Curve and Peak Expiratory Flow

Gastroesophageal reflux following peroral endoscopic myotomy for achalasia: Bumps in the road to success

Effectiveness of Peroral Endoscopic Myotomy in the Treatment of Achalasia: A Pilot Trial in Chinese Han Population with a Minimum of One‐year Follow‐up

Clinical and nutritional correlates associated with weight changes in achalasia patients and the impact of laparoscopic Heller myotomy